The company and all members of the board guarantee that the content of the information disclosure is true, accurate, and complete, with no false records, misleading statements, or significant omissions.
Securities Code: 301207
Securities Abbreviation: Hualan Vaccine
Announcement No.: 2026-004
301207SZSE
Announcement of Resolutions from the 18th Meeting of the 2nd Board of Directors
✨ AI Summary
The 18th meeting of the 2nd Board of Directors of Hualan Biological Bacterin Co., Ltd. was held on February 27, 2026. The board approved the proposal to continue using up to RMB 1 billion of idle raised funds for cash management, ensuring it does not affect project investments or normal operations. This cash management will be valid for 12 months from the approval date.
Summary generated by AI · Always verify with source document
Full Translation
AI Translation· azure_openai
Sign in to read the full translation
Free accounts get 10 full releases per month. Pro subscribers get unlimited access.